USPTO serial 78807660
LIFEFORCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMAS, AMY E
- Law office
- TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LIFEFORCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | (Based on Intent to Use)(Based on 44(e)) Biological materials in the nature of tissue, namely blood, stem cells,umbilical cords and placentas for scientific and medical research use | ACTIVE | — |
| 005 | (Based on Intent to Use) (Based on 44(e)) Medicinal, pharmaceutical, prophylactic and therapeutic preparations for use in contingent autologous transplantation therapy; medicinal, pharmaceutical, prophylactic and therapeutic biological materials, namely blood and blood components for subsequent implantation, blood, blood components and fractions, cellular material, namely blood components for transplantation; cellular material, namely blood components for autotransplantation; blood, blood fractions and blood components for medical, therapeutic or prophylactic purposes; blood components and fractions for injection purposes; blood components and fractions for autotransplantation; blood components and fractions for transfusion, blood components and fractions for adoptive immunotherapy; blood components and fractions for contingent autologous transplantation; leukocyte preparations for medical use; leukocyte-enriched blood fractions for medical use; isolated leukocytes for medical use; leukocyte preparations for cryopreservation and adoptive immunotherapy medical use; cryopreserved blood for medical use; cryopreserved blood fractions and components for medical use; cryopreserved leukocyte preparations for medical use; cryopreserved leukocyte-enriched blood fractions for medical use; cryopreserved isolated leukocytes for medical use; T-cell preparations for medical or clinical use; B-cell preparations for medical or clinical use; cryopreserved T - cells for medical or clinical use; cryopreserved B-cells for medical or clinical use; blood, blood components and fractions for contingent autologous transplantation therapy; leukocyte preparations, leukocyte-enriched blood fractions and isolated leukocytes for contingent autologous transplantation therapy | ACTIVE | — |
| 009 | (Based on Intent to Use) (Based on 44(e)) Data banks featuring information regarding cell donors and recorded on a magnetic data carrier; scientific apparatus and instruments for processing data relating to cell banks; apparatus for recording, transmission or reproduction of data relating to cell banks; magnetic data carriers bearing data relating to cell banks and the maintenance thereof data processors and computers for use with cell banks and parts, components and fittings therefor | ACTIVE | — |
| 010 | (Based on Intent to Use) (Based on 44(e)) Blood processing or fractionating apparatus and instruments for medical purposes; medical apparatus and instruments for the isolation of blood cells or blood components; medical apparatus and instruments for the isolation of leukocytes; medical apparatus and instruments for the analysis of blood, blood fractions or blood components; leukapheresis apparatus for medical purposes, leukapheresis tubing sets for medical purposes; blood press packs, namely, containers for the manipulation of blood and blood fractions, blood presses, namely, medical apparatus for use with blood press packs, blood collection apparatus and instruments; medical apparatus for cell cryopreservation; medical apparatus for cryopreservation of blood, blood fractions or blood components; medical apparatus for cryopreservation of leukocytes, B-cells or T-cells; vessels for containing cryopreserved biological material; vessels for containing cryopreserved blood, blood fractions or blood components; vessels for containing cryopreserved leukocytes; vessels for containing cryopreserved B-cells or T-cells; parts and fittings therefor | ACTIVE | — |
| 039 | (Based on Use in Commerce) (Based on 44(e)) Storage of biological tissues; storage of blood cells; storage of leukocytes, B-cells or T-cells; cryogenic storage of biological tissue or cells; cryogenic storage of biological tissue intended for subsequent implantation, transfusion, injection, transplantation or autotransplantation, storage of blood fractions, blood components, leukocytes, T-cells or B-cells, cryogenic storage of blood, blood fractions, blood components, leukocytes, T-cells or B-cells; storage of blood fractions, blood components, leukocytes, T-cells or B-cells intended for subsequent implantation, transfusion, injection, transplantation or autotransplantation; cryogenic storage of blood, blood fractions, blood components, leukocytes, T-cells or B-cells intended for subsequent implantation, transfusion, injection, transplantation or autotransplantation | ACTIVE | Dec 31, 2002 |
| 044 | (Based on Use in Commerce) (Based on 44(e)) Medical services; medical services, namely, immunotherapy services; blood processing services, namely the collection and preservation of human blood; medical services, namely, implantation, leukapheresis, transfusion, injection, transplantation and autotransplantation services; medical services, namely, cellular implantation, transfusion, injection, transplantation or autotransplantation services; medical services, namely, implantation, transfusion, injection, transplantation or autotransplantation services relating to leukocytes, T-cells or B-cells; blood bank services; cell and biological tissue bank services; leukocyte bank services; T-cell and B-cell bank services; banks of blood components, fractions and preparations; blood cell banks; blood sampling and collection services; medical services, namely, blood fractionation and treatment; analytical services for blood for medical purposes; medical services, namely, autologous leukocyte transplantation; medical services, namely, contingent autologous leukocyte transplantation; medical clinics; immunotherapy clinics; implantation, transfusion, injection, transplantation or autotransplantation clinics; blood bank clinics; blood donation centers; blood collection clinics; clinics for autologous leukocyte transplantation; clinics for contingent autologous leukocyte transplantation; health care; hospital services; nursing services; physical therapy; pharmacy advice; physiotherapy, sports medicine services; consultancy services relating to surgery | ACTIVE | Dec 31, 2002 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lifeforce Immune System Bank PLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 039
- Other trademarks in Class 044
- Similar marks named LIFEFORCE
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 14, 2011 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 14, 2011 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 18, 2011 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 18, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 27, 2011 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 14, 2010 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 8, 2010 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 6, 2009 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 6, 2009 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 6, 2008 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 3, 2008 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 3, 2007 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 2, 2007 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 2, 2007 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 12, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 12, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2007 | ALIE | ASSIGNED TO LIE | — |
| Feb 5, 2007 | PAPER RECEIVED | — | |
| Aug 2, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2006 | NWAP | NEW APPLICATION ENTERED | — |